21 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
committee has assessed the independence of Pearl Meyer consistent with Nasdaq listing standards and has concluded that the engagement does not raise any … responsibilities.
The nominating and corporate governance committee may also consider factors such as judgment, diversity, independence, skills, education
8-K
g057w
14 Jul 21
Departure of Directors or Certain Officers
8:19am
8-K
o48tsx fi52
26 Apr 21
Departure of Directors or Certain Officers
8:05am
8-K
c04x4txfon0in w058j
10 Jun 20
Departure of Directors or Certain Officers
8:36am
DEF 14A
wtf6 n3qczf
27 Apr 20
Definitive proxy
7:30am
10-K
EX-10.12
vy21y30i1v4
16 Mar 20
Annual report
5:17pm
10-K
yi64jia8gykg77yaqh4
16 Mar 20
Annual report
5:17pm
8-K
zoxi6frw1b6zl7mab4tu
6 Sep 19
Departure of Directors or Certain Officers
4:34pm
424B4
dcg n8f304qf
20 Jun 19
Prospectus supplement with pricing info
5:20pm
S-1/A
ib06c4s6
10 Jun 19
IPO registration (amended)
11:16am
S-1
76xlv8e2x 8tqll
24 May 19
IPO registration
4:18pm
DRS/A
f5eu6go
30 Apr 19
Draft registration statement (amended)
12:00am
DRS/A
3cahtjqc
19 Mar 19
Draft registration statement (amended)
12:00am